文献速递脑血管病神经重症与神经感染

自动化大血管闭塞检测软件与取栓治疗时间:一项整群随机临床试验

Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2023-01-01

该整群随机阶梯楔形临床试验在得克萨斯州大休斯敦地区4个综合卒中中心开展,评估人工智能自动检测大血管闭塞联合安全消息推送对院内血管内治疗流程的影响。结果显示,软件实施与门-腹股沟时间缩短11.2分钟(95%CI,-18.22至-4.2)相关,CT启动至EVT开始时间缩短9.8分钟(95%CI,-16.9至-2.6),但静脉tPA治疗时间、住院时长及90天功能独立无差异。

要点

  • AI自动检测大血管闭塞联合手机安全消息推送可缩短门-腹股沟时间。
  • CT启动至EVT开始时间缩短9.8分钟(95%CI,-16.9至-2.6)。
  • 静脉tPA治疗时间、住院时长及90天功能独立无显著差异。

核心结论

  • 自动化大血管闭塞检测联合基于手机应用的安全通讯改善了院内急性缺血性卒中流程。
  • 软件实施与EVT治疗时间具有临床意义的缩短相关。

研究设计与样本

  • 整群随机阶梯楔形临床试验,于2021年1月1日至2022年2月27日在得克萨斯州大休斯敦地区4个综合卒中中心开展。
  • 共443例经急诊就诊的大血管闭塞卒中患者接受EVT,排除外院转入158例、院内卒中39例及因大核心临床试验随机化接受EVT的3例后,243例纳入分析。
  • 暴露期103例,非暴露期140例;完整队列中位年龄70岁(IQR,58-79),女性122例(50%)。
  • 干预为人工智能自动检测CT血管造影大血管闭塞联合安全消息推送,按随机阶梯方式在4个中心激活。

主要发现

  • 混合效应线性回归显示,AI算法实施与门-腹股沟时间缩短11.2分钟相关(95%CI,-18.22至-4.2)。
  • CT扫描启动至EVT开始时间缩短9.8分钟(95%CI,-16.9至-2.6)。
  • 静脉tPA治疗时间及住院时长无差异。
  • 校正年龄、美国国立卫生研究院卒中量表评分及Alberta卒中项目早期CT评分后,功能独立(改良Rankin量表评分0-2)的可能性无差异(比值比1.3;95%CI,0.42-4.0)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The benefit of endovascular stroke therapy (EVT) in large vessel occlusion (LVO) ischemic stroke is highly time dependent. Process improvements to accelerate in-hospital workflows are critical. OBJECTIVE: To determine whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital EVT workflows. DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized stepped-wedge clinical trial took place from January 1, 2021, through February 27, 2022, at 4 comprehensive stroke centers (CSCs) in the greater Houston, Texas, area. All 443 participants with LVO stroke who presented through the emergency department were treated with EVT at the 4 CSCs. Exclusion criteria included patients presenting as transfers from an outside hospital (n = 158), in-hospital stroke (n = 39), and patients treated with EVT through randomization in a large core clinical trial (n = 3). INTERVENTION: Artificial intelligence (AI)-enabled automated LVO detection from CT angiogram coupled with secure messaging was activated at the 4 CSCs in a random-stepped fashion. Once activated, clinicians and radiologists received real-time alerts to their mobile phones notifying them of possible LVO within minutes of CT imaging completion. MAIN OUTCOMES AND MEASURES: Primary outcome was the effect of AI-enabled LVO detection on door-to-groin (DTG) time and was measured using a mixed-effects linear regression model, which included a random effect for cluster (CSC) and a fixed effect for exposure status (pre-AI vs post-AI). Secondary outcomes included time from hospital arrival to intravenous tissue plasminogen activator (IV tPA) bolus in eligible patients, time from initiation of CT scan to start of EVT, and hospital length of stay. In exploratory analysis, the study team evaluated the impact of AI implementation on 90-day modified Rankin Scale disability outcomes. RESULTS: Among 243 patients who met inclusion criteria, 140 were treated during the unexposed period and 103 during the exposed period. Median age for the complete cohort was 70 (IQR, 58-79) years and 122 were female (50%). Median National Institutes of Health Stroke Scale score at presentation was 17 (IQR, 11-22) and the median DTG preexposure was 100 (IQR, 81-116) minutes. In mixed-effects linear regression, implementation of the AI algorithm was associated with a reduction in DTG time by 11.2 minutes (95% CI, -18.22 to -4.2). Time from CT scan initiation to EVT start fell by 9.8 minutes (95% CI, -16.9 to -2.6). There were no differences in IV tPA treatment times nor hospital length of stay. In multivariable logistic regression adjusted for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference in likelihood of functional independence (modified Rankin Scale score, 0-2; odds ratio, 1.3; 95% CI, 0.42-4.0). CONCLUSIONS AND RELEVANCE: Automated LVO detection coupled with secure mobile phone application-based communication improved in-hospital acute ischemic stroke workflows. Software implementation was associated with clinically meaningful reductions in EVT treatment times. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05838456.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Martinez-Gutierrez JC, Kim Y, Salazar-Marioni S, et al. Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial. JAMA Neurol. 2023. PMID: 37721738. doi:10.1001/jamaneurol.2023.3206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。